REGENERX BIOPHARMACEUTICALS, INC. Business Development
REGENERX BIOPHARMACEUTICALS, INC. reported Business Development of $7.28 million for the 1-month period ending 2015-03-31, per its 10-Q filed 2016-05-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessDevelopment · last filed 2016-05-16
- 2015-03-31: Business Development 1 month $7.28M.
- 2015-03-09: Business Development 0 month $7.28M.
| Period end | Business Development 0 month | Business Development 1 month |
|---|---|---|
| 2015-03-31 | $7.28M 10-Q · filed 2016-05-16 | |
| 2015-03-09 | $7.28M 10-Q · filed 2015-05-15 |